These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14163287)

  • 1. [THE USE OF A BUTYROPHENONE NEUROLEPTIC (HALOPERIDOL) IN ACUTE AND CHRONIC PSYCHOSES].
    MADALENA JC; FERREIRA LR; BELLO H
    Rev Assoc Med Bras; 1963; 9():375-86. PubMed ID: 14163287
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the therapeutic effects of a butyrophenone (R-1625--Haloperidin--haloperidol) in psychoses].
    PALAIOLOGOS A; SIGALOS I; SPATHARAS G; TERENTIOS E
    Hell Iatr; 1963 May; 32():473-502. PubMed ID: 13941173
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trials of a new neuroleptic of the butyrophenone group].
    VELLOSO FM; PAPROCKI J
    Hospital (Rio J); 1963 Jun; 63():1427-34. PubMed ID: 13996630
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psycho-pharmacological study of a 5th butyrophenone: "methylperidide", a neuroleptic pyrrolidinamide and methyl derivative of haloperidol].
    DIVRY P; BOBON J; COLLARD J; DEMARET A
    Acta Neurol Psychiatr Belg; 1960 Dec; 60():1073-86. PubMed ID: 13723131
    [No Abstract]   [Full Text] [Related]  

  • 5. [CLINICO-THERAPEUTIC TRIALS WITH DIPIPERON, A NEW BUTYROPHENONE SERIES DERIVATIVE].
    SCHWARZ H; KRUEGER HJ; JUENEMANN HJ
    Acta Neurol Psychiatr Belg; 1964 Apr; 64():401-12. PubMed ID: 14176013
    [No Abstract]   [Full Text] [Related]  

  • 6. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice.
    López-Muñoz F; Alamo C
    Brain Res Bull; 2009 Apr; 79(2):130-41. PubMed ID: 19186209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HUNTINGTON'S CHOREA, TEMPERAMENT DISORDERS OF MANIAC EXPRESSION. BENEFICIAL EFFECTS OF HALOPERIDOL (FLUORO-PHENYL-PIPERIDINE BUTYROPHENONE). ABSENCE OF THE THERAPEUTIC AKINETO-HYPERTONIC SYNDROME].
    NAYRAC P; ARNOTT G; MILBLED G
    Lille Med; 1964 Oct; 9():765-8. PubMed ID: 14210922
    [No Abstract]   [Full Text] [Related]  

  • 8. [OUR EXPERIENCES WITH A NEW MAJOR NEUROLEPTIC: HALOPERIDOL].
    GALINDEZ L; SANTOS MR; BOREL RO
    Dia Med; 1963 Sep; 35():1435-6. PubMed ID: 14088362
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of a neuroleptic agent of the butyrophenone series (2028 MD) in clinical E.E.G].
    MORIN G; VIGNOT P; BOUCHACOURT A
    Rev Neurol (Paris); 1960 Sep; 103():272-5. PubMed ID: 13772670
    [No Abstract]   [Full Text] [Related]  

  • 10. [C.B. 8089 (FLUORIZED BUTYROPHENONE) IN STATES OF PSYCHOMOTOR AGITATION AND IN CHARACTER DISORDERS AT ALL AGES (EXCEPT CHILDHOOD)].
    CHATAGNON PA; CHATAGNON C
    Ann Med Psychol (Paris); 1964 May; 122():809-16. PubMed ID: 14150706
    [No Abstract]   [Full Text] [Related]  

  • 11. [A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses].
    DELAY J; PICHOT P; LEMPERIERE T; ELISSALDE B; PEIGNE F
    Ann Med Psychol (Paris); 1960 Jan; 118(1)():145-52. PubMed ID: 13815606
    [No Abstract]   [Full Text] [Related]  

  • 12. [CONTRIBUTION OF ELECTROENCEPHALOGRAPHY TO THE STUDY OF COMBINATIONS OF PSYCHOTROPIC DRUGS].
    MONTANINI R; RAVASINI C
    Riv Neurol; 1964; 34():359-67. PubMed ID: 14208878
    [No Abstract]   [Full Text] [Related]  

  • 13. [CLINICAL TRIAL OF A NEW NEUROLEPTIC IN LABOR. 4-(4-HYDROXY-4-PHENYL-PIPERIDINE)-BUTYROPHENONE].
    ARDILLO L; MAINARDI C
    Minerva Ginecol; 1965 Jan; 17():133-6. PubMed ID: 14299812
    [No Abstract]   [Full Text] [Related]  

  • 14. INFLUENCE OF FOUR BUTYROPHENONE NEUROLEPTICS ON RAT BRAIN NORADRENALINE DEPLETORY EFFECT OF RESERPINE.
    DRESSE A; DEMEYER R
    Life Sci (1962); 1964 Jul; 3():759-62. PubMed ID: 14203976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic utilization in clinical EEG of a neuroleptic butyrophenone: MD-2028].
    MORIN G; BOUCHACOURT A; VIGNOT P; COULONJOU R
    Presse Med (1893); 1961 Apr; 69():915-6. PubMed ID: 13772666
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new neuroleptic with delayed hypnogenic effect: dipiperon (R3345), butyrophenone carbamide].
    BOBON J; COLLARD J; DEMARET A
    Acta Neurol Psychiatr Belg; 1961 Jul; 61():611-30. PubMed ID: 13870300
    [No Abstract]   [Full Text] [Related]  

  • 17. [CLINICAL EXPERIENCE WITH A NEW NEUROLEPTIC: R 1625 OR HALOPERIDOL].
    ACUSSERUIZ DG; MALUF L
    Prensa Med Argent; 1963 Aug; 50():2348-55. PubMed ID: 14102409
    [No Abstract]   [Full Text] [Related]  

  • 18. [New viewpoints in neuroleptic therapy of acute and chronic psychoses. Report on clinical evaluation of a new thiaxanthene derivative].
    MARX H; KRUEGER H
    Nervenarzt; 1962 Oct; 33():469-72. PubMed ID: 13933221
    [No Abstract]   [Full Text] [Related]  

  • 19. [A SPECIFIC MEDICATION FOR CHOREIC MOVEMENT, 4'-FLUORO-4-(4-(P-CHLOROPHENYL)-4-HYDROXYPIPERIDINO)-BUTYROPHENONE OR R-1625 (HALOPERIDOL)].
    NICK J; NICOLLE MH
    Bull Mem Soc Med Hop Paris; 1964 Feb 7-14; 115():275-80. PubMed ID: 14136521
    [No Abstract]   [Full Text] [Related]  

  • 20. [A PARADOXICAL REACTION TO NEUROLEPTICS (EXCITOMOTOR SYNDROME)].
    VISSER SL
    Ned Tijdschr Geneeskd; 1963 Nov; 107():2230-2. PubMed ID: 14095457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.